Vimarsana
Biggest News Aggregation in the World

Frank Sciurba News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Frank Sciurba. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Frank Sciurba Today - Breaking & Trending Today

KLAS 8 News Now At Noon January 4, 2016 - Vimarsana News

KLAS 8 News Now At Noon January 4, 2016

The group set up camp saturday after a march in a nearby town in support of two ranchers. Dwight hammond and his son steven were convicted of setting fires on federal land in 2001. And in 2006 served jail time. They say it wasnt arson, but controlled burns to protect their property. In october a judge added four more years to their sentence. Ammon bundy is leading the occupation. He says theyre fighting back against the governments expansion of the over 100 yearold federal wildlife refuge at the expense of local ranchers. ammon bundy rancher there have been some tremendous abuses. They used th...

Spirometry clinical trial eligibility may differ with race-neutral equations - Vimarsana News

Spirometry clinical trial eligibility may differ with race-neutral equations

Equations that don't use racially and ethnically adjusted spirometry results to help determine eligibility for chronic obstructive pulmonary disease (COPD) clinical trials may lead to higher percentages of Black patients enrolled, according to research published at the ATS 2024 International Conference.

Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at ATS 2024 - Vimarsana News

Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at ATS 2024

PDUFA Target Action Date of June 26, 2024 Eight posters including two oral presentations support potential of ensifentrine,an investigational, first-in-class, selective, dual inhibitor of PDE3 and...

Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at CHEST 2023 - Vimarsana News

Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at CHEST 2023

PDUFA Target Action Date of June 26, 2024 Pooled analysis and subgroup data further support potential of ensifentrine, an investigational, novel, selective, dual inhibitor of PDE3 and PDE4 LONDON...

Galvanize Therapeutics Completes Enrollment in Pivotal Trial of RheOx® System for Chronic Bronchitis - Vimarsana News

Galvanize Therapeutics Completes Enrollment in Pivotal Trial of RheOx® System for Chronic Bronchitis

/PRNewswire/ -- Galvanize Therapeutics, Inc., a leader in developing pulsed electric field (PEF) therapies for COPD, soft tissue, and cardiac arrhythmias, has...